H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Email

[email protected]

Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

Get In Touch

Safety Alert

Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23

Published
11 May 2026
Source
Alerts and Recalls for Drugs and Medical Devices - All
Imported
6 Jun 2026
Original alert
https://www.gov.uk/drug-device-alerts/c…
Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.
View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - All
All alerts from this source
More from Alerts and Recalls for Drugs and M…
Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution fo… 4 Jun 2026
Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp… 2 Jun 2026
Field Safety Notices: 25 to 29 May 2026 2 Jun 2026
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25 28 May 2026
Field Safety Notices: 18 -22 May 2026 28 May 2026
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts